365 related articles for article (PubMed ID: 29886242)
1. Conflicting roles of 20-HETE in hypertension and renal end organ damage.
Zhang C; Booz GW; Yu Q; He X; Wang S; Fan F
Eur J Pharmacol; 2018 Aug; 833():190-200. PubMed ID: 29886242
[TBL] [Abstract][Full Text] [Related]
2. 20-HETE and blood pressure regulation: clinical implications.
Wu CC; Gupta T; Garcia V; Ding Y; Schwartzman ML
Cardiol Rev; 2014; 22(1):1-12. PubMed ID: 23584425
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin II receptor blockade or deletion of vascular endothelial ACE does not prevent vascular dysfunction and remodeling in 20-HETE-dependent hypertension.
Garcia V; Joseph G; Shkolnik B; Ding Y; Zhang FF; Gotlinger K; Falck JR; Dakarapu R; Capdevila JH; Bernstein KE; Schwartzman ML
Am J Physiol Regul Integr Comp Physiol; 2015 Jul; 309(1):R71-8. PubMed ID: 25924878
[TBL] [Abstract][Full Text] [Related]
4. 20-hydroxyeicosatetraeonic acid: a new target for the treatment of hypertension.
Williams JM; Murphy S; Burke M; Roman RJ
J Cardiovasc Pharmacol; 2010 Oct; 56(4):336-44. PubMed ID: 20930591
[TBL] [Abstract][Full Text] [Related]
5. The role of 20-HETE in androgen-mediated hypertension.
Wu CC; Schwartzman ML
Prostaglandins Other Lipid Mediat; 2011 Nov; 96(1-4):45-53. PubMed ID: 21722750
[TBL] [Abstract][Full Text] [Related]
6. 20-HETE Signals Through G-Protein-Coupled Receptor GPR75 (G
Garcia V; Gilani A; Shkolnik B; Pandey V; Zhang FF; Dakarapu R; Gandham SK; Reddy NR; Graves JP; Gruzdev A; Zeldin DC; Capdevila JH; Falck JR; Schwartzman ML
Circ Res; 2017 May; 120(11):1776-1788. PubMed ID: 28325781
[TBL] [Abstract][Full Text] [Related]
7. Abnormal pressure-natriuresis in hypertension: role of cytochrome P450 metabolites of arachidonic acid.
Moreno C; Maier KG; Hoagland KM; Yu M; Roman RJ
Am J Hypertens; 2001 Jun; 14(6 Pt 2):90S-97S. PubMed ID: 11411771
[TBL] [Abstract][Full Text] [Related]
8. N-Palmitoylethanolamide protects the kidney from hypertensive injury in spontaneously hypertensive rats via inhibition of oxidative stress.
Mattace Raso G; Simeoli R; Russo R; Santoro A; Pirozzi C; d'Emmanuele di Villa Bianca R; Mitidieri E; Paciello O; Pagano TB; Orefice NS; Meli R; Calignano A
Pharmacol Res; 2013 Oct; 76():67-76. PubMed ID: 23917217
[TBL] [Abstract][Full Text] [Related]
9. CYP4A2-induced hypertension is 20-hydroxyeicosatetraenoic acid- and angiotensin II-dependent.
Sodhi K; Wu CC; Cheng J; Gotlinger K; Inoue K; Goli M; Falck JR; Abraham NG; Schwartzman ML
Hypertension; 2010 Nov; 56(5):871-8. PubMed ID: 20837888
[TBL] [Abstract][Full Text] [Related]
10. P-450 metabolites of arachidonic acid in the control of cardiovascular function.
Roman RJ
Physiol Rev; 2002 Jan; 82(1):131-85. PubMed ID: 11773611
[TBL] [Abstract][Full Text] [Related]
11. Role of cytochrome P450 metabolites of arachidonic acid in hypertension.
Sarkis A; Roman RJ
Curr Drug Metab; 2004 Jun; 5(3):245-56. PubMed ID: 15180494
[TBL] [Abstract][Full Text] [Related]
12. Cytochrome P450 metabolites of arachidonic acid in the control of renal function.
Maier KG; Roman RJ
Curr Opin Nephrol Hypertens; 2001 Jan; 10(1):81-7. PubMed ID: 11195057
[TBL] [Abstract][Full Text] [Related]
13. Epoxyeicosatrienoic acids, 20-hydroxyeicosatetraenoic acid, and renal microvascular function.
Imig JD
Prostaglandins Other Lipid Mediat; 2013; 104-105():2-7. PubMed ID: 23333581
[TBL] [Abstract][Full Text] [Related]
14. Induction of angiotensin-converting enzyme and activation of the renin-angiotensin system contribute to 20-hydroxyeicosatetraenoic acid-mediated endothelial dysfunction.
Cheng J; Garcia V; Ding Y; Wu CC; Thakar K; Falck JR; Ramu E; Schwartzman ML
Arterioscler Thromb Vasc Biol; 2012 Aug; 32(8):1917-24. PubMed ID: 22723444
[TBL] [Abstract][Full Text] [Related]
15. Role of cytochrome P450-dependent arachidonic acid metabolites in liver physiology and pathophysiology.
Sacerdoti D; Gatta A; McGiff JC
Prostaglandins Other Lipid Mediat; 2003 Oct; 72(1-2):51-71. PubMed ID: 14626496
[TBL] [Abstract][Full Text] [Related]
16. The CYP/20-HETE/GPR75 axis in hypertension.
Froogh G; Garcia V; Laniado Schwartzman M
Adv Pharmacol; 2022; 94():1-25. PubMed ID: 35659370
[TBL] [Abstract][Full Text] [Related]
17. 20-HETE in the regulation of vascular and cardiac function.
Rocic P; Schwartzman ML
Pharmacol Ther; 2018 Dec; 192():74-87. PubMed ID: 30048707
[TBL] [Abstract][Full Text] [Related]
18. Renal P450 metabolites of arachidonic acid and the development of hypertension in Dahl salt-sensitive rats.
Roman RJ; Alonso-Galicia M; Wilson TW
Am J Hypertens; 1997 May; 10(5 Pt 2):63S-67S. PubMed ID: 9160783
[TBL] [Abstract][Full Text] [Related]
19. 20-Hydroxyeicosatetraenoic acid is an endogenous vasoconstrictor of canine renal arcuate arteries.
Ma YH; Gebremedhin D; Schwartzman ML; Falck JR; Clark JE; Masters BS; Harder DR; Roman RJ
Circ Res; 1993 Jan; 72(1):126-36. PubMed ID: 8417836
[TBL] [Abstract][Full Text] [Related]
20. Kidney CYP450 enzymes: biological actions beyond drug metabolism.
Zhao X; Imig JD
Curr Drug Metab; 2003 Feb; 4(1):73-84. PubMed ID: 12570747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
